(Q46972620)

27 December 2017

title

Rome Foundation Endpoints and Outcomes Conference 2009: Optimizing Clinical Trials in FGID. (English)

1 reference

27 December 2017

author name string

Lin Chang

series ordinal

1

1 reference

27 December 2017

Douglas A Drossman

series ordinal

2

1 reference

27 December 2017

language of work or name

English

0 references

publication date

1 April 2010

1 reference

27 December 2017

The American Journal of Gastroenterology

published in

1 reference

27 December 2017

volume

105

1 reference

27 December 2017

issue

4

1 reference

27 December 2017

page(s)

722-730

1 reference

27 December 2017

Functional bowel disorders

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.49

Functional gastroduodenal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.49

Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome Foundation report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.49

The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.49

A phase II trial of the novel serotonin type 3 receptor antagonist ramosetron in Japanese male and female patients with diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.49

Design of treatment trials for functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.49

Measurement of health status. Ascertaining the minimal clinically important difference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.49

The trials and tribulations of drug development for functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.49

International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.49

Irritable bowel syndrome: toward an understanding of severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.49

A focus group assessment of patient perspectives on irritable bowel syndrome and illness severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.49

Predictors of patient-assessed illness severity in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.49

Childhood functional gastrointestinal disorders: child/adolescent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.49

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.49

The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.49

Development and content validity of a gastroparesis cardinal symptom index daily diary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.49

21 January 2018

Identifiers

DOI

10.1038/AJG.2010.49

1 reference

27 December 2017

1 reference

27 December 2017